A Framework for Promoting Diversity, Equity, and Inclusion in Genetics and Genomics Research.

IMPORTANCE Research into the genetic and genomic ("genomics") foundations of disease is central to our understanding of disease prevention, early detection, diagnostic accuracy, and therapeutic intervention. Inequitable participation in genomics research by historically excluded populations limits the ability to translate genomic knowledge to achieve health equity and ensure that findings are generalizable to diverse populations. OBSERVATIONS We propose a novel framework for promoting diversity, equity, and inclusion in genomics research. Building on principles of community-based participatory research and collective impact frameworks, the framework can guide our understanding of the social, cultural, health system, policy, community, and individual contexts in which engagement and genomics research are being done. Our framework highlights the involvement of a multistakeholder team, including the participants and communities to be engaged, to ensure robust methods for recruitment, retention, return of genomic results, quality of engagement, follow-up, and monitoring of participants. CONCLUSIONS AND RELEVANCE The proposed engagement framework will guide investigators in optimizing equitable representation in research and enhancing the rigor of genomics investigation.

[1]  E. Glisky,et al.  Two separate, large cohorts reveal potential modifiers of age-associated variation in visual reaction time performance , 2021, npj Aging and Mechanisms of Disease.

[2]  M. Davis Genomics and Cancer Disparities: The Justice and Power of Inclusion. , 2021, Cancer discovery.

[3]  W. Al-Delaimy,et al.  Minority Representation in Clinical Trials in the United States: Trends Over the Past 25 Years. , 2021, Mayo Clinic proceedings.

[4]  K. D. Sørensen,et al.  Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction , 2021, Nature genetics.

[5]  P. Kantoff,et al.  Racial Differences in Genomic Profiling of Prostate Cancer. , 2020, The New England journal of medicine.

[6]  Keolu Fox The Illusion of Inclusion - The "All of Us" Research Program and Indigenous Peoples' DNA. , 2020, The New England journal of medicine.

[7]  M. Frey,et al.  Racial and Ethnic Disparities in Genetic Testing at a Hereditary Breast and Ovarian Cancer Center , 2020, Journal of General Internal Medicine.

[8]  John J. Connolly,et al.  Participant choices for return of genomic results in the eMERGE Network , 2020, Genetics in Medicine.

[9]  Nikki M. Carroll,et al.  Return of Research-Related Genetic Test Results and Genetic Discrimination Concerns: Facilitators and Barriers of Genetic Research Participation in Diverse Groups , 2020, Public Health Genomics.

[10]  E. V. Van Allen,et al.  Engaging Patients in Precision Oncology: Development and Usability of a Web-Based Patient-Facing Genomic Sequencing Report. , 2020, JCO precision oncology.

[11]  P. Spicer,et al.  An Alaska Native community’s views on genetic research, testing, and return of results: Results from a public deliberation , 2020, PloS one.

[12]  J. Kania,et al.  Collective Impact , 2020, Encyclopedia of the UN Sustainable Development Goals.

[13]  Tara Berman,et al.  Adverse childhood experiences and associated health outcomes: A systematic review and meta-analysis. , 2019, Child abuse & neglect.

[14]  E. Lander,et al.  The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research , 2019, Nature Medicine.

[15]  A. Philippakis,et al.  The "All of Us" Research Program. , 2019, The New England journal of medicine.

[16]  S. Block,et al.  Adolescent and Young Adult Cancer Patients’ Experiences With Treatment Decision-making , 2019, Pediatrics.

[17]  Alicia R. Martin,et al.  Clinical use of current polygenic risk scores may exacerbate health disparities , 2019, Nature Genetics.

[18]  K. Kalmakis,et al.  A model for trauma-informed primary care , 2019, Journal of the American Association of Nurse Practitioners.

[19]  Rachel M. Sherman,et al.  Assembly of a pan-genome from deep sequencing of 910 humans of African descent , 2018, Nature Genetics.

[20]  Eliezer M. Van Allen,et al.  Interactive or static reports to guide clinical interpretation of cancer genomics , 2018, J. Am. Medical Informatics Assoc..

[21]  E. Acosta-Pérez,et al.  The Use of Community Engaged Research Principles to Improve Health: Community Academic Partnerships for Research. , 2017, Puerto Rico health sciences journal.

[22]  Peter Szolovits,et al.  Genetic Misdiagnoses and the Potential for Health Disparities. , 2016, The New England journal of medicine.

[23]  S. Fullerton,et al.  Using Genetic Technologies To Reduce, Rather Than Widen, Health Disparities. , 2016, Health affairs.

[24]  Adithya Cattamanchi,et al.  Strategies for implementing implementation science: a methodological overview , 2016, Emergency Medicine Journal.

[25]  Heidi L Rehm,et al.  Return of genomic results to research participants: the floor, the ceiling, and the choices in between. , 2014, American journal of human genetics.

[26]  Jane C Weeks,et al.  Physicians' attitudes about multiplex tumor genomic testing. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  A. McGuire,et al.  Social and behavioral research in genomic sequencing: approaches from the Clinical Sequencing Exploratory Research Consortium Outcomes and Measures Working Group , 2014, Genetics in Medicine.

[28]  Michael A. Yonas,et al.  PCOR, CER, and CBPR: Alphabet Soup or Complementary Fields of Health Research? , 2013, Clinical and translational science.

[29]  B. Knoppers,et al.  Population studies: return of research results and incidental findings Policy Statement , 2012, European Journal of Human Genetics.

[30]  John P. A. Ioannidis,et al.  Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective. , 2012, JAMA.

[31]  Leslie G. Biesecker,et al.  Opportunities and challenges for the integration of massively parallel genomic sequencing into clinical practice: lessons from the ClinSeq project , 2012, Genetics in Medicine.

[32]  Marian Reiff,et al.  “What does it mean?”: Uncertainties in understanding results of chromosomal microarray testing , 2012, Genetics in Medicine.

[33]  Douglas E Levy,et al.  Underutilization of BRCA1/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at risk , 2011, Genetics in Medicine.

[34]  Rebecca R. Cheezum,et al.  Community-based participatory research: a capacity-building approach for policy advocacy aimed at eliminating health disparities. , 2010, American journal of public health.

[35]  R. Glasgow,et al.  Evaluating the public health impact of health promotion interventions: the RE-AIM framework. , 1999, American journal of public health.

[36]  H. Lynch,et al.  Psychologic Aspects of Cancer Genetic Testing: A Research Update for Clinicians , 1997 .